Parkinson Disease: 5 Updates

Pain related to more severe motor symptoms, phosphodiesterase 10A loss seen early, novel therapy shows promise, and other recent findings are summarized here.

Related Videos
Related Content

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

March 25th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

FDA Issues Complete Response Letter for AbbVie’s 24-Hour Continuous Carbidopa/Levodopa Pump

March 22nd 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Impaired Decision-Making Symptom Significantly Associated in Cerebellar Ataxia

March 18th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

March 25th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

FDA Issues Complete Response Letter for AbbVie’s 24-Hour Continuous Carbidopa/Levodopa Pump

March 22nd 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Impaired Decision-Making Symptom Significantly Associated in Cerebellar Ataxia

March 18th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

March 25th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

FDA Issues Complete Response Letter for AbbVie’s 24-Hour Continuous Carbidopa/Levodopa Pump

March 22nd 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Impaired Decision-Making Symptom Significantly Associated in Cerebellar Ataxia

March 18th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023
© 2023 MJH Life Sciences

All rights reserved.